2 results, showing 1 to 2
After conducting market inquiries, the Commission determined that the merger between SmithKline Beecham (Australia) Pty Ltd and Glaxo Wellcome Ltd, to form Glaxo SmithKline plc, would not substantially effect competition, provided that certain Undertakings be provided by SmithKline Beecham to the ACCC.
The Undertaking provides that SmithKline Beecham will sell its Famvir product to Novartis AG in the event that the merger proceeds.
Jutco Pty Ltd has provided a section 87B undertaking to the ACCC in respect of the supply of vehicle and trolley jacks which do not comply with the mandatory safety standard.
Jutco Pty Ltd has already placed product recall notices in all major Australian newspapers and has undertaken to write to all suppliers to which it supplies jacks advising that previously supplied jacks may not comply to standards and to return non-compliant stocks for relabelling or refund.
Jutco Pty Ltd has undertaken to implement a trade practices compliance program.
No results found
No results found